Cargando…
Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801976/ https://www.ncbi.nlm.nih.gov/pubmed/36591292 http://dx.doi.org/10.3389/fimmu.2022.1093403 |
| _version_ | 1784861597892608000 |
|---|---|
| author | Zheng, Hao Zheng, Wen-juan Wang, Zhen-guang Tao, Yuan-ping Huang, Zhi-ping Yang, Le Ouyang, Liu Duan, Zhi-qing Zhang, Yi-nuo Chen, Bo-ning Xiang, Dai-min Jin, Gang Fang, Lu Zhou, Fan Liang, Bo |
| author_facet | Zheng, Hao Zheng, Wen-juan Wang, Zhen-guang Tao, Yuan-ping Huang, Zhi-ping Yang, Le Ouyang, Liu Duan, Zhi-qing Zhang, Yi-nuo Chen, Bo-ning Xiang, Dai-min Jin, Gang Fang, Lu Zhou, Fan Liang, Bo |
| author_sort | Zheng, Hao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9801976 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98019762022-12-31 Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity Zheng, Hao Zheng, Wen-juan Wang, Zhen-guang Tao, Yuan-ping Huang, Zhi-ping Yang, Le Ouyang, Liu Duan, Zhi-qing Zhang, Yi-nuo Chen, Bo-ning Xiang, Dai-min Jin, Gang Fang, Lu Zhou, Fan Liang, Bo Front Immunol Immunology Frontiers Media S.A. 2022-12-08 /pmc/articles/PMC9801976/ /pubmed/36591292 http://dx.doi.org/10.3389/fimmu.2022.1093403 Text en Copyright © 2022 Zheng, Zheng, Wang, Tao, Huang, Yang, Ouyang, Duan, Zhang, Chen, Xiang, Jin, Fang, Zhou and Liang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Zheng, Hao Zheng, Wen-juan Wang, Zhen-guang Tao, Yuan-ping Huang, Zhi-ping Yang, Le Ouyang, Liu Duan, Zhi-qing Zhang, Yi-nuo Chen, Bo-ning Xiang, Dai-min Jin, Gang Fang, Lu Zhou, Fan Liang, Bo Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity |
| title | Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity |
| title_full | Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity |
| title_fullStr | Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity |
| title_full_unstemmed | Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity |
| title_short | Corrigendum: Decreased expression of programmed death ligand-L1 by seven in absentia homolog 2 in cholangiocarcinoma enhances T-cell–mediated antitumor activity |
| title_sort | corrigendum: decreased expression of programmed death ligand-l1 by seven in absentia homolog 2 in cholangiocarcinoma enhances t-cell–mediated antitumor activity |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801976/ https://www.ncbi.nlm.nih.gov/pubmed/36591292 http://dx.doi.org/10.3389/fimmu.2022.1093403 |
| work_keys_str_mv | AT zhenghao corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT zhengwenjuan corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT wangzhenguang corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT taoyuanping corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT huangzhiping corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT yangle corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT ouyangliu corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT duanzhiqing corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT zhangyinuo corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT chenboning corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT xiangdaimin corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT jingang corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT fanglu corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT zhoufan corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity AT liangbo corrigendumdecreasedexpressionofprogrammeddeathligandl1byseveninabsentiahomolog2incholangiocarcinomaenhancestcellmediatedantitumoractivity |